麦澜德跌2.02%，成交额711.96万元，主力资金净流入68.69万元

Core Viewpoint - 麦澜德's stock price has shown significant volatility, with a year-to-date increase of 73.20%, but a recent decline of 4.53% over the past five trading days, indicating potential market fluctuations and investor sentiment changes [1][2]. Company Overview - 南京麦澜德医疗科技股份有限公司, established on January 16, 2013, and listed on August 11, 2022, specializes in the research, production, sales, and services related to pelvic and postpartum rehabilitation products [1]. - The company's revenue composition includes: pelvic rehabilitation products (36.98%), reproductive rehabilitation products (33.10%), consumables and accessories (24.32%), sports rehabilitation products (2.77%), and other products (2.84%) [1]. Financial Performance - For the period from January to September 2025, 麦澜德 reported a revenue of 344 million yuan, reflecting a year-on-year growth of 4.01%, while the net profit attributable to shareholders was approximately 95.6 million yuan, showing a slight decrease of 0.07% [2]. - Since its A-share listing, 麦澜德 has distributed a total of 268 million yuan in dividends [3]. Shareholder and Market Activity - As of September 30, 2025, 麦澜德 had 6,402 shareholders, an increase of 17.23% from the previous period, with an average of 5,752 circulating shares per shareholder, down by 14.70% [2]. - The stock has seen significant trading activity, with a recent net inflow of 686,900 yuan from major funds, indicating ongoing interest from institutional investors [1].